1395346-28-7: Deferasirox Salicyloyl Ester
Deferasirox Salicyloyl Ester Cas No. 1395346-28-7 with IUPAC Name 4-(3-(2-((2-hydroxybenzoyl)oxy)phenyl)-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl)benzoic acid is an impurity of Deferasirox which is mainly used to reduce chronic iron overload in patients receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. The first oral medication approved in the United States for this purpose is Deferasirox.
Additional information on CAS 1395346-28-7
VE008731
1395346-28-7
C28H19N3O6
493.5 g/mol
Deferasirox
4-(3-(2-((2-hydroxybenzoyl)oxy)phenyl)-5-(2-hydroxyphenyl)-1H-1, 2, 4-triazol-1-yl)benzoic acid
N/A
Choudhry, V. P., and Rahul Naithani. “Current Status of Iron Overload and Chelation with Deferasirox.” The Indian Journal of Pediatrics, vol. 74, no. 8, Aug. 2007, pp. 759–64, https://doi.org/10.1007/s12098-007-0134-7.
In-stock
Other products related to deferasirox
CAS No. | Name of Impurity | Parent Drug | Catalogue No. |
---|